Unlocking Dental Solutions, Empowering GBR Success
Technology Excellence
Purgo Biologics has endeavored to contribute from the development of global dental treatment and clinical science to the improvement of human oral health by continuously supplying products through scientific and structured processes over the past 20 years to clinical professionals around the world.
Company Milestones
Foundation
1999 - Established Purgo Biologics
2000 - Concluded Domestic supply contract with ACE Surgical Supply (USA)
2001 - Concluded domestic supply contract with Hartzell and Son (USA)
2002 - Signed a distributor contract with Rocky Mountain Tissue Bank (USA)
2003 - Signed an exclusive distributor contract in Asia of Biomatlante (France), Released sales of Happylon®
2005 - Established Purgo Tissue Bank, Released domestic sales of suture of Shirakawa (Japan)
Bone & Membrane Specialization
2010 - Established Purgo R&D Center (Pangyo)
2011 - Obtained Certificate of Manufacturer of Medical Devices from Korean MFDS
2012 - Received Certificate of Registration of Quality Management System ISO 13485:2016 - Obtained CE certificate of OpenTex, Obtained KGMP (Korea Good Manufacturing Practice) Korean MFDS certificate
2013 - THE Graft was approved as a manufacturer item by Korean MFDS, Obtained TFDA (Taiwan) certificate of OpenTex, Obtained CMDCAS certificate of OpenTex,
Concluded domestic supply contract of resorbable collagen membrane, Authorized as a venture company
Global Growth
2014 - Biotex was approved as a manufacturer item by the Korean MFDA
2015 - OpenTex-TR was approved as a manufactured item by Korean MFDA; Obtained TFDA (Taiwan) & CE certificate of THE Graft, Concluded global sales contract of THE Graft in 18 EU countries
2016 - The factory and laboratory were relocated to cover global supply, A randomized clinical trial lecture of THE Graft was published in SCI journal
2017 - Obtained CE certificate of THE Graft, OpenTex, OpenTex-TR, BioTex, Obtained Health Canada certificate of THE Graft, OpenTex, OprenTex-TR, BioTex,
Obtained Roszdravnadzor (Russia) certificate of THE Graft, OpenTex, OprenTex-TR, BioTex, Concluded supply contract in Portugal, Spain & Canada, Selected as a specialist company in human resource development
Ｅｍｐｏｗｅｒｉｎｇ ＧＢＲ Ｓｕｃｃｅｓｓ
2018 - Obtained MDSAP certificate (ISO 13485:2016), Obtained FDA, CDSCO certificate of THE Graft, Obtained ANVISA (Brazil) certificate of Biotex, Selected as Frontier Export Company
2019 - Obtained certificate of THE Graft in Ukraine, Obtained FDA (USA) certificate of Biotex, Obtained NMPA (CFDA) certificate of THE Graft
2020 - Built up the "Strategic Cooperative Partnership" with CareCapital
2021 - Purgo HQ moved to Pangyo Technovalley,
Purgo Europe Branch opening as Europe Importer
CORE FOCUS
Purgo focus on Bone & Membrane Only
Innovation
Excellence
Regeneration
Biomimetics
Science & Technology
